ISCOMATRIX

 

Topic mentions per year

Topic mentions per year

1999-2016
02419992016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Vaccination strategies based on repeated injections of NY-ESO-1 protein formulated in ISCOMATRIX particles (NY-ESO-1 ISCOMATRIX… (More)
Is this relevant?
2012
2012
Pulmonary delivery of an influenza Iscomatrix adjuvant vaccine induces a strong systemic and mucosal antibody response. Since an… (More)
  • figure 1
  • figure 2
  • table 1
Is this relevant?
2010
2010
ISCOMATRIX() adjuvant is a component of a variety of developmental vaccines. To evaluate the safety profile of ISCOMATRIX… (More)
Is this relevant?
2009
2009
Cancer vaccines aim to induce antitumor CTL responses, which require cross-presentation of tumor Ag to CTLs by dendritic cells… (More)
  • figure 2
  • figure 1
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2009
2009
The effectiveness of single dose, intranasally delivered vaccines comprising detergent-disrupted inactivated influenza virus… (More)
Is this relevant?
2008
2008
An important obstacle to development of an effective vaccine against Helicobacter pylori is the lack of a suitable adjuvant. This… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
Dendritic cells (DCs) are being evaluated for cancer immunotherapy due to their unique ability to induce tumor-directed T-cell… (More)
Is this relevant?
Highly Cited
2004
Highly Cited
2004
NY-ESO-1 is a "cancer-testis" antigen expressed in many cancers. ISCOMATRIX is a saponin-based adjuvant that induces antibody and… (More)
Is this relevant?
2004
2004
Human Papillomavirus type 16 (HPV16) E6 and E7 oncoproteins are associated with cervical cancer development and progression and… (More)
Is this relevant?
2003
2003
Mucosal delivery of inactivated vaccines that are able to elicit protective immune responses against respiratory diseases has… (More)
Is this relevant?